| Literature DB >> 35164054 |
Syed Tawab Shah1, Zaira Zaman Chowdhury1, Mohd Rafie Bin Johan1, Irfan Anjum Badruddin2,3, H M T Khaleed4, Sarfaraz Kamangar2, Hussein Alrobei5.
Abstract
Functionalized magnetite nanoparticles (Fe3O4) were prepared using the coprecipitation method followed by functionalization with a multipotent antioxidant (MPAO). The MPAO was synthesized and analyzed using FTIR and NMR techniques. In this study, the functionalized nanoparticles (IONP@AO) were produced and evaluated using the FTIR, XRD, Raman, HRTEM, FESEM, VSM, and EDX techniques. The average determined particle size of IONP@AO was 10 nanometers. In addition, it demonstrated superparamagnetic properties. The magnitude of saturation magnetization value attained was 45 emu g-1. Virtual screenings of the MPAO's potential bioactivities and safety profile were performed using PASS analysis and ADMET studies before the synthesis step. For the DPPH test, IONP@AO was found to have a four-fold greater ability to scavenge free radicals than unfunctional IONP. The antimicrobial properties of IONP@AO were also demonstrated against a variety of bacteria and fungi. The interaction of developed nanoantioxiants with biomolecules makes it a broad-spectrum candidate in biomedicine and nanomedicine.Entities:
Keywords: functionalization; magnetite nanoparticles; nanoantioxiants
Mesh:
Substances:
Year: 2022 PMID: 35164054 PMCID: PMC8840749 DOI: 10.3390/molecules27030789
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Surface Functional Groups identification using Fourier-transform infrared spectra of IONP@AO.
Figure 2Raman spectra of IONP@AO.
Figure 3X-ray Diffraction spectra of IONP@AO.
Figure 4VSM of IONP@AO.
Figure 5HRTEM images (A) Unfunctionalized IONP. (B) functionalized IONP@AO showing particle size distribution.
EDX Elemental Analysis of IONP@AO.
| Sample | Fe | O | C | S |
|---|---|---|---|---|
| IONP | 69.4 | 30.6 | - | - |
| IONP@AO | 68.2 | 25.3 | 6.5 | 0.1 |
Figure 6(A) FESEM image, EDX and elemental map of Fe, O of IONP. (B) FESEM image, EDX and elemental map of Fe, O, C and S of IONP@AO.
Predicted ADMET Properties from Computational Analysis.
|
| |
| Number of rotatable bonds | 13 |
| Number of H-bond acceptors | 5 |
| Number of H-bond donors | 1 |
| MR | 116.67 |
| TPSA | 90.29 |
|
| |
| iLOGP | 4.58 |
| XLOGP3 | 4.98 |
| WLOGP | 4.27 |
| MLOGP | 2.99 |
| Silicos-IT LogP | 5.62 |
| Consensus LogP | 4.49 |
|
| |
| ESOL Log S | −4.84 |
| ESOL Solubility (mg/mL) | 6.02 × 10−3 |
| ESOL Solubility (mol/l) | 1.46 × 10−5 |
| ESOL Class | Moderately soluble |
|
| |
| GI absorption | High |
| BBB permeant | No |
| Pgp substrate | No |
| CYP1A2 inhibitor | No |
| CYP2C19 inhibitor | No |
| CYP2C9 inhibitor | No |
| CYP2D6 inhibitor | Yes |
| CYP3A4 inhibitor | Yes |
| log Kp (cm/s) | −5.28 |
|
| |
| Lipinski number of violations | 0 |
| Ghose number of violations | 0 |
| Veber number of violations | 1 |
| Egan number of violations | 0 |
| Muegge number of violations | 0 |
| Bioavailability Score | 0.55 |
|
| |
| PAINS number of alerts | 0 |
| Brenk number of alerts | 0 |
| Leadlikeness number of violations | 3 |
| Synthetic Accessibility | 3.89 |
Figure 7(A) polar surface area. (B) Molecular Lipophilicity Potential (MLP) and (C) boiled egg predictive model of MPAO.
Part of the predicted biological activity spectra of the MPAO based on PASS prediction software.
| a Pa | b Pi | Biological Activity |
|---|---|---|
| 0.456 | 0.013 | Free radical scavenger |
| 0.351 | 0.049 | Lipid peroxidase inhibitor |
| 0.285 | 0.026 | Antioxidant |
| 0.268 | 0.097 | Antifungal |
| 0.224 | 0.098 | Antibacterial |
a Probability “to be active”. b Probability “to be inactive”.
Figure 8(A) UV–Visible Spectrum. (B) DPPH Scavenging percentage by IONP@AO at different concentrations.
IC50 of IONP@AO.
| IC50 a Values (mg) ± S.E.M b and Max. Inhibition % | |||
|---|---|---|---|
| Sample | IC50 mg/mL | % Inhibition | |
| IONP | 5 mg | 4.7 ± 0.002 | 50 |
| IONP@AO | 5 mg | 1 ± 0.002 | 83 |
a IC50, 50% effective concentration. b S.E.M, standard error of the mean.
Figure 9Percentage of inhibition (POI) of (A) bacterial growth and (B) fungal growth, after treatment with IONP@AO.
Figure 10(A) Synthesis of MPAO. (B) Synthesis of IONP. (C) The functionalization of IONPs.